Question to the Department for Business, Energy and Industrial Strategy:

To ask the Secretary of State for Business, Energy and Industrial Strategy, how many individual covid-19 vaccine doses the Government (a) has used, (b) has in stock, (c) is due to receive as part of signed contractual agreements with suppliers and (d) has committed to share through Covax.

As of 1 July, the total number of doses that have been administered is 77,592,212.

The UK Government has secured early access to 397 million vaccine doses through supply agreements with six separate vaccine developers, of which four have received regulatory approval and three are currently in deployment. This includes agreements with:

• Pfizer/BioNTech for 100 million doses (in deployment)
• University of Oxford/AstraZeneca for 100 million doses (in deployment)
• Moderna for 17 million doses (in deployment)
• Janssen for 20 million doses (approved)
• Novavax for 60 million doses
• Valneva for 100 million doses

In addition, the Government has a reservation agreement with GlaxoSmithKline/Sanofi Pasteur for 60 million doses and a non-binding agreement with CureVac for 50 million doses.

The Government has announced that the UK will donate at least 100 million surplus COVID-19 vaccine doses within the next year, including 5 million by the end of September 2021 and a further 25 million by the end of 2021.

The Government has committed that 80% of our surplus vaccines will go to COVAX, the multilateral facility responsible for distributing COVID-19 vaccines to ensure equitable global access. The remainder will be shared bilaterally with countries in need and we will set out further details in due course.